At the terminal experimental protocol, the obese group showed higher levels of serum insulin (Figure 2c) and HOMA‐IR (Figure 2d) compared to the control group, confirming the presence of insulin resistance in the obese group. The gene discussed is INS; the disease is Insulin resistance.